Vitamin D3: The Deficiency You Probably Have, Why the Standard Range Is Probably Wrong, and What to Take
Vitamin D deficiency is estimated to affect 40–80% of adults in northern latitudes. The standard sufficiency threshold (50 nmol/L serum 25(OH)D) is set for bone health. For immune function, mortality risk, and chronic disease prevention, the evidence points to a higher target. Here's the mechanism and the evidence.
Vitamin D is not technically a vitamin — it is a prohormone, produced in skin by UV-B radiation acting on 7-dehydrocholesterol, and then hydroxylated in the liver (25-hydroxyvitamin D, the storage form measured in blood) and again in the kidney (1,25-dihydroxyvitamin D, the active form). The target cells: essentially every cell in the body, via vitamin D receptors (VDRs) that are among the most broadly distributed nuclear receptors in human physiology.
The Deficiency Epidemic
Vitamin D deficiency is estimated at:
- 40% of the US adult population (by the sufficiency criterion of 50 nmol/L)
- 70–80% in Northern European and Scandinavian populations in winter
- Nearly universal in populations spending most daylight hours indoors regardless of latitude
The primary source is cutaneous synthesis — dietary vitamin D (from fatty fish, eggs, fortified foods) contributes a minority of total requirement in sun-exposed populations. For populations with minimal sun exposure, dietary intake is functionally the only source, and dietary sources are inadequate across most populations to maintain sufficiency.
What Vitamin D Does
Bone metabolism: The classical function. Active vitamin D is required for intestinal calcium absorption and bone mineralization. Deficiency → calcium absorption falls → bone turnover increases to maintain serum calcium → bone density decreases. Rickets (children), osteomalacia (adults), and osteoporosis are the end-stage conditions.
Immune function: VDRs are expressed on most immune cells. Active vitamin D modulates both innate and adaptive immunity — promoting antimicrobial peptide production in macrophages (cathelicidin, defensins), modulating T-cell differentiation toward regulatory rather than inflammatory phenotypes, and reducing excessive inflammatory cytokine production. The epidemiological association between low vitamin D status and autoimmune disease is substantial.
Non-skeletal outcomes: Meta-analyses show associations between vitamin D deficiency and increased risk of cardiovascular disease, type 2 diabetes, certain cancers (particularly colorectal), all-cause mortality, and depression. Causality is debated for some of these associations, but all-cause mortality data is particularly robust.
> 📌 Autier et al. (2014) reviewing 172 observational studies found consistent inverse associations between serum 25(OH)D and multiple disease outcomes, but noted that RCTs using supplementation showed smaller or absent effects — suggesting that low vitamin D may partly be a marker of ill health and inflammation (reverse causality) rather than purely a cause. However, more recent RCTs with higher doses show significant effects on some endpoints, and the mortality data remains strong. [1]
The Dosing Question
Standard supplement dose recommendations: 400–800 IU/day. This is established to be nearly universally inadequate for maintaining serum 25(OH)D above 50 nmol/L in the absence of sun exposure.
Functional doses for maintaining optimal range (75–125 nmol/L in most authorities):
- 1,000–2,000 IU/day for maintenance in mildly deficient individuals with some sun exposure
- 3,000–4,000 IU/day for correction and maintenance in clearly deficient individuals or those with minimal sun exposure
- Testing serum 25(OH)D is the definitive approach — dose to achieve 75–100 nmol/L
Take with the largest fat-containing meal of the day (D3 is fat-soluble). D3 (cholecalciferol) is superior to D2 (ergocalciferol) for raising and maintaining serum levels.
---
Key Terms
- 25(OH)D (25-hydroxyvitamin D) — the serum storage form of vitamin D measured in blood tests; reflects total vitamin D status from both cutaneous synthesis and dietary intake; the clinical biomarker for vitamin D deficiency assessment
- VDR (vitamin D receptor) — the nuclear receptor expressed in essentially every cell type; mediates genomic effects of active vitamin D (1,25(OH)₂D); among the most broadly distributed nuclear receptors, explaining vitamin D's wide functional reach
- Cholecalciferol (D3) — the form of vitamin D3 produced in human skin and found in animal-source foods; superior to ergocalciferol (D2) in raising and maintaining serum 25(OH)D; the preferred supplemental form
- Reverse causality — the methodological concern that associations between low vitamin D and disease reflect that illness lowers vitamin D levels, rather than that low vitamin D causes illness; a genuine confounder in observational vitamin D research
---
Scientific Sources
- 1. Autier, P., et al. (2014). Vitamin D status and ill health: A systematic review. The Lancet Diabetes & Endocrinology, 2(1), 76–89. PubMed
- 2. Bouillon, R., et al. (2019). Vitamin D and human health: Lessons from vitamin D receptor null mice. Endocrine Reviews, 29(6), 726–776. PubMed
This is additional material. For the complete system — the psychology, the biology, and the step-by-step method — read the book.
Read The Book →